187 related articles for article (PubMed ID: 34849607)
1. Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.
Donnelly LL; Hogan TC; Lenahan SM; Nandagopal G; Eaton JG; Lebeau MA; McCann CL; Sarausky HM; Hampel KJ; Armstrong JD; Cameron MP; Sidiropoulos N; Deming P; Seward DJ
Carcinogenesis; 2021 Dec; 42(12):1428-1438. PubMed ID: 34849607
[TBL] [Abstract][Full Text] [Related]
2. Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy.
Mazzaschi G; Leonetti A; Minari R; Gnetti L; Quaini F; Tiseo M; Facchinetti F
Curr Treat Options Oncol; 2021 Sep; 22(11):96. PubMed ID: 34524570
[TBL] [Abstract][Full Text] [Related]
3. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
[TBL] [Abstract][Full Text] [Related]
4. LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.
Facchinetti F; Bluthgen MV; Tergemina-Clain G; Faivre L; Pignon JP; Planchard D; Remon J; Soria JC; Lacroix L; Besse B
Lung Cancer; 2017 Oct; 112():62-68. PubMed ID: 29191602
[TBL] [Abstract][Full Text] [Related]
5. Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional
Pore N; Wu S; Standifer N; Jure-Kunkel M; de Los Reyes M; Shrestha Y; Halpin R; Rothstein R; Mulgrew K; Blackmore S; Martin P; Meekin J; Griffin M; Bisha I; Proia TA; Miragaia RJ; Herbst R; Gupta A; Abdullah SE; Raja R; Frigault MM; Barrett JC; Dennis PA; Ascierto ML; Oberst MD
Cancer Discov; 2021 Nov; 11(11):2828-2845. PubMed ID: 34230008
[TBL] [Abstract][Full Text] [Related]
6. Emerging Therapeutic Implications of STK11 Mutation: Case Series.
Laderian B; Mundi P; Fojo T; E Bates S
Oncologist; 2020 Sep; 25(9):733-737. PubMed ID: 32396674
[TBL] [Abstract][Full Text] [Related]
7. STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
Di Federico A; De Giglio A; Parisi C; Gelsomino F
Eur J Cancer; 2021 Nov; 157():108-113. PubMed ID: 34500370
[TBL] [Abstract][Full Text] [Related]
8.
Sitthideatphaiboon P; Galan-Cobo A; Negrao MV; Qu X; Poteete A; Zhang F; Liu DD; Lewis WE; Kemp HN; Lewis J; Rinsurongkawong W; Giri U; Lee JJ; Zhang J; Roth JA; Swisher S; Heymach JV
Clin Cancer Res; 2021 Mar; 27(6):1720-1733. PubMed ID: 33323404
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer.
Rosellini P; Amintas S; Caumont C; Veillon R; Galland-Girodet S; Cuguillière A; Nguyen L; Domblides C; Gouverneur A; Merlio JP; Bezin J; Girodet PO
Eur J Cancer; 2022 Sep; 172():85-95. PubMed ID: 35759814
[TBL] [Abstract][Full Text] [Related]
10.
Papillon-Cavanagh S; Doshi P; Dobrin R; Szustakowski J; Walsh AM
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32312757
[TBL] [Abstract][Full Text] [Related]
11. Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
Guibert N; Jones G; Beeler JF; Plagnol V; Morris C; Mourlanette J; Delaunay M; Keller L; Rouquette I; Favre G; Pradines A; Mazieres J
Lung Cancer; 2019 Nov; 137():1-6. PubMed ID: 31518912
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer.
Wohlhieter CA; Richards AL; Uddin F; Hulton CH; Quintanal-Villalonga À; Martin A; de Stanchina E; Bhanot U; Asher M; Shah NS; Hayatt O; Buonocore DJ; Rekhtman N; Shen R; Arbour KC; Donoghue M; Poirier JT; Sen T; Rudin CM
Cell Rep; 2020 Dec; 33(9):108444. PubMed ID: 33264619
[TBL] [Abstract][Full Text] [Related]
13. Hot spot mutations in Finnish non-small cell lung cancers.
Mäki-Nevala S; Sarhadi VK; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuuttila A; Knuutila S
Lung Cancer; 2016 Sep; 99():102-10. PubMed ID: 27565922
[TBL] [Abstract][Full Text] [Related]
14. A STING operation to expose KRAS and STK11 co-mutated lung cancers.
Skoulidis F; Heymach JV; Cascone T
Cancer Cell; 2022 Oct; 40(10):1073-1076. PubMed ID: 36220070
[TBL] [Abstract][Full Text] [Related]
15. A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.
Chen L; Engel BE; Welsh EA; Yoder SJ; Brantley SG; Chen DT; Beg AA; Cao C; Kaye FJ; Haura EB; Schabath MB; Cress WD
J Thorac Oncol; 2016 Jun; 11(6):838-49. PubMed ID: 26917230
[TBL] [Abstract][Full Text] [Related]
16.
Skoulidis F; Goldberg ME; Greenawalt DM; Hellmann MD; Awad MM; Gainor JF; Schrock AB; Hartmaier RJ; Trabucco SE; Gay L; Ali SM; Elvin JA; Singal G; Ross JS; Fabrizio D; Szabo PM; Chang H; Sasson A; Srinivasan S; Kirov S; Szustakowski J; Vitazka P; Edwards R; Bufill JA; Sharma N; Ou SI; Peled N; Spigel DR; Rizvi H; Aguilar EJ; Carter BW; Erasmus J; Halpenny DF; Plodkowski AJ; Long NM; Nishino M; Denning WL; Galan-Cobo A; Hamdi H; Hirz T; Tong P; Wang J; Rodriguez-Canales J; Villalobos PA; Parra ER; Kalhor N; Sholl LM; Sauter JL; Jungbluth AA; Mino-Kenudson M; Azimi R; Elamin YY; Zhang J; Leonardi GC; Jiang F; Wong KK; Lee JJ; Papadimitrakopoulou VA; Wistuba II; Miller VA; Frampton GM; Wolchok JD; Shaw AT; Jänne PA; Stephens PJ; Rudin CM; Geese WJ; Albacker LA; Heymach JV
Cancer Discov; 2018 Jul; 8(7):822-835. PubMed ID: 29773717
[No Abstract] [Full Text] [Related]
17. STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines.
Lenahan SM; Sarausky HM; Deming P; Seward DJ
Cancer Gene Ther; 2024 Jan; 31(1):1-8. PubMed ID: 37968341
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.
Ricciuti B; Elkrief A; Alessi J; Wang X; Li Y; Gupta H; Muldoon DM; Bertram AA; Pecci F; Lamberti G; Di Federico A; Barrichello A; Vaz VR; Gandhi M; Lee E; Shapiro GI; Park H; Nishino M; Lindsay J; Felt KD; Sharma B; Cherniack AD; Rodig S; Gomez DR; Shaverdian N; Rakaee M; Bandlamudi C; Ladanyi M; Janne PA; Schoenfeld AJ; Sholl LM; Awad MM; Cheng ML
Clin Cancer Res; 2023 Jul; 29(13):2540-2550. PubMed ID: 37097610
[TBL] [Abstract][Full Text] [Related]
19. Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.
Pécuchet N; Laurent-Puig P; Mansuet-Lupo A; Legras A; Alifano M; Pallier K; Didelot A; Gibault L; Danel C; Just PA; Riquet M; Le Pimpec-Barthes F; Damotte D; Fabre E; Blons H
Oncotarget; 2017 Apr; 8(14):23831-23840. PubMed ID: 26625312
[TBL] [Abstract][Full Text] [Related]
20. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
